Antoní Torres

Active 1984–2025

Also published as
Antoni Torres · ANTONI TORRES
426
Papers
72,951
Citations
141
h-index
412
i10-index

Citations

Citations per year for Antoní Torres1967: 1 citations1977: 2 citations1986: 1 citations1987: 2 citations1988: 4 citations1989: 9 citations1990: 17 citations1991: 28 citations1992: 34 citations1993: 55 citations1994: 49 citations1995: 92 citations1996: 94 citations1997: 84 citations1998: 137 citations1999: 164 citations2000: 183 citations2001: 248 citations2002: 238 citations2003: 267 citations2004: 329 citations2005: 318 citations2006: 339 citations2007: 307 citations2008: 346 citations2009: 415 citations2010: 338 citations2011: 395 citations2012: 391 citations2013: 341 citations2014: 352 citations2015: 291 citations2016: 368 citations2017: 346 citations2018: 422 citations2019: 1,477 citations2020: 1,640 citations2021: 2,015 citations2022: 1,687 citations2023: 1,142 citations2024: 2,130 citations2025: 1,063 citations2026: 33 citations1968–1976: no citations, so these years are not shown1978–1985: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,787 citing papers, 19% of this breakdownChina: 1,559 citing papers, 7.8% of this breakdownUnited Kingdom: 1,521 citing papers, 7.6% of this breakdownSpain: 1,488 citing papers, 7.4% of this breakdownItaly: 1,067 citing papers, 5.3% of this breakdownFrance: 1,057 citing papers, 5.3% of this breakdownGermany: 837 citing papers, 4.2% of this breakdownCanada: 666 citing papers, 3.3% of this breakdownNetherlands: 603 citing papers, 3% of this breakdownAustralia: 573 citing papers, 2.9% of this breakdownSwitzerland: 461 citing papers, 2.3% of this breakdownBelgium: 411 citing papers, 2.1% of this breakdown
0%19%Other 29.8%

Fields

  • Medicine73.4%
  • Biochemistry, Genetics and Molecular Biology10.8%
  • Immunology and Microbiology8.9%
  • Health Professions1.6%
  • Engineering0.9%
  • Nursing0.9%
  • Other3.5%

Topics

  • Pneumonia and Respiratory Infections8%
  • Nosocomial Infections in ICU7.8%
  • Respiratory Support and Mechanisms4.9%
  • Sepsis Diagnosis and Treatment4.2%
  • Antibiotic Use and Resistance4%
  • Antibiotic Resistance in Bacteria3.7%
  • Other67.4%

Coauthors

All papers

Open in search
  1. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia

    Authors: , , , , , , , , , , , , , , , - European Respiratory Journal 2017 cited by 1,395

  2. Pneumonia

    Authors: , , , , , , - Nature Reviews Disease Primers 2021 cited by 806

  3. European Respiratory Society guidelines for the management of adult bronchiectasis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - European Respiratory Journal 2017 cited by 1,344

  4. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

    Authors: , , , , , , , , , , , - Clinical Infectious Diseases 2007 cited by 6,244

  5. Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC)

    Authors: , , , , , , , , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2023 cited by 280

  6. How to use biomarkers of infection or sepsis at the bedside: guide to clinicians

    Authors: , , , , , , , , , , , , , , - Intensive Care Medicine 2023 cited by 280

  7. Current gaps in sepsis immunology: new opportunities for translational research

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Infectious Diseases 2019 cited by 381

  8. An Updated Definition and Severity Classification of Chronic Obstructive Pulmonary Disease Exacerbations: The Rome Proposal

    Authors: , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2021 cited by 337

  9. Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tobias Welte, Robert C. Wilson, Conroy Wong, James D. Chalmers - The Lancet Respiratory Medicine 2021 cited by 285

  10. Profiling the dysregulated immune response in sepsis: overcoming challenges to achieve the goal of precision medicine

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2023 cited by 188

  11. ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia

    Authors: , , , , , , , , , , , , , , , , , , , , , - European Respiratory Journal 2023 cited by 285

  12. Programmed ‘disarming’ of the neutrophil proteome reduces the magnitude of inflammation

    Authors: , , , , , , , , , , , , , , , , - Nature Immunology 2020 cited by 280

  13. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lorena de la Mora, Jhon Rojas, Laura Linares, Berta Fidalgo, Natàlia Rodríguez, David Nicolás, Laia Albiach, José Muñóz, Alex Almuedo-Riera, Daniel Camprubí, Ma Ángeles Marcos, Daniel Camprubí, Catia Cillóniz, Sara Fernández, José M. Nicolás, Antoni Torres - Clinical Microbiology and Infection 2020 cited by 1,051

  14. Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial

    Authors: , , , , , , , , , , - The Lancet Infectious Diseases 2017 cited by 443

  15. Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - European Respiratory Journal 2017 cited by 448

  16. Bronchiectasis in India: results from the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) and Respiratory Research Network of India Registry

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Saurabh Karmakar, Virendra Singh, Surinder K. Jindal, Shubham Sharma, Deepak Prajapat, Sagar Chandrashekaria, Melissa J. McDonnell, Aditi Mishra, Robert Rutherford, Ramanathan Palaniappan Ramanathan, Pieter Goeminne, Preethi Vasudev, Katerina Dimakou, Megan Crichton, Biiligere Siddaiah Jayaraj, Rahul Kungwani, Akanksha Das, Mehneet Sawhney, Eva Polverino, Antoní Torres, Nayan Sri Gulecha, Michal Shteinberg, Anthony De Soyza, Anshul Mangala, Palak Shah, Nishant Kumar Chauhan, Nikita Jajodia, Ashutosh Singhal, Sakshi Batra, Ashfaq Hasan, Sneha Limaye, Sundeep Salvi, Stefano Aliberti, James D. Chalmers - The Lancet Global Health 2019 cited by 238

  17. Treatment of Community-Acquired Pneumonia in Immunocompromised Adults

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Takaya Maruyama, Rosario Menéndez, Mark L. Metersky, Donna Mildvan, Eric M. Mortensen, Michael S. Niederman, Mathias W. Pletz, Jordi Rello, Marcos I. Restrepo, Yuichiro Shindo, Antoní Torres, Grant Waterer, Brandon Webb, Tobias Welte, Martin Witzenrath, Richard G. Wunderink - CHEST Journal 2020 cited by 233

  18. Effect of Corticosteroids on Treatment Failure Among Hospitalized Patients With Severe Community-Acquired Pneumonia and High Inflammatory Response

    Authors: , , , , , , , , , , , - JAMA 2015 cited by 564

  19. Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Antonio Oliver, Olivier Barraud, Terramika Bellamy, Marc J. M. Bonten, Herman Goossens, Colin Reisner, Mark T. Esser, Hasan S. Jafri, The COMBACTE-MAGNET EVADE Study Group, Michael Joannidis, Walter Klimscha, Elisabeth De Waele, Jacques Devriendt, Vincent Huberlant, Pieter Depuydt, Sam Van Boxstael, Mladen Perić, Jasminka Kopić, Michal Hanauer, Tomas Hruby, Vladimír Šrámek, Petr Svoboda, Tomáš Vymazal, Martin Nováček, Djillali Annane, Jean‐Paul Mira, Bertrand Souweine, Pierre‐François Dequin, Ferhat Meziani, François Stéphan, Saadalla Nseir, Sébastien Gibot, Carole Schwebel, Gaëtan Plantefève, Jean‐Luc Diehl, Christian Richard, Christian Lamer, Kada Klouche, Samir Jaber, Epaminondas Zakynthinos, Georgios Filntisis, Spyros Zakynthinos, Antonia Koutsoukou, Georgios Saroglou, Charikleia Nikolaou, Glykeria Vlachogianni, Ioannis Pnevmatikos, Konstantinos Mandragos, Ildikó Krémer, Zsolt Dezso Rozgonyi, Zsuzsa Marjanek, Ignacio Martín‐Loeches, Pierre Singer, Vernon van Heerden, Yehuda Carmeli, Pedro Póvoa, Antonio Alvarez Seoane, Pedro Henrique de Moura, Filipe Gonzalez, Paula Ramírez, Antonio Torres Martí, Ricard Ferrer, Lorena Oteiza, D. Escudero, Enrique Piacentini, Paula Vera, Luis Tamayo, Miguel Angel Gonzalez Gallego, B. Suberviola Cañas, Iglesias Figueira and 18 more - Critical Care 2022 cited by 93

  20. Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , José A. Vázquez, Joost Wauters, Erika Asperges, Andrea Cortegiani, Cecilia Grecchi, Ilias Karaiskos, Clément Le Bihan, Toine Mercier, Klaus Leth Mortensen, Maddalena Peghin, Chiara Rebuffi, Sofía Tejada, Antonio Vena, Valentina Zuccaro, Luigia Scudeller, Thierry Calandra, Claire Roger, Christian Eckmann, Jean‐Pierre Gangneux, Esther Segal, Geoffrey W. Coombs, Andreas Voß - Intensive Care Medicine 2024 cited by 171

  21. Determining the most accurate 16S rRNA hypervariable region for taxonomic identification from respiratory samples

    Authors: , , , , , , , , - Scientific Reports 2023 cited by 101

  22. Guidelines for the management of adult lower respiratory tract infections - Full version

    Authors: , , , , , , , , , , , - Clinical Microbiology and Infection 2011 cited by 951

  23. Risk factors for community-acquired pneumonia in adults in Europe: a literature review

    Authors: , , , - Thorax 2013 cited by 858

  24. The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mihai G. Netea, Tom van der Poll, Jesús F. Bermejo-Martín, Ignacio Rubio - The Lancet Respiratory Medicine 2021 cited by 573